Tanya M Laidlaw
Overview
Explore the profile of Tanya M Laidlaw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
4313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bunn K, Bressman Z, Nation G, Wu P, Amin T, Lehman C, et al.
Am J Respir Cell Mol Biol
. 2025 Mar;
PMID: 40085481
Extracellular vesicles (EVs) are membrane-bound particles secreted by cells with emerging roles in intercellular communication during tissue homeostasis and disease. Although EVs are abundant in respiratory biofluids, their cellular sources,...
2.
3.
Derakhshan T, Hollers E, Perniss A, Ryan T, McGill A, Hacker J, et al.
J Clin Invest
. 2025 Jan;
135(1).
PMID: 39744949
Mast cells (MCs) expressing a distinctive protease phenotype (MCTs) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MCTs are phenotypically distinct from subepithelial...
4.
Laidlaw T
Curr Opin Allergy Clin Immunol
. 2024 Dec;
25(1):41-46.
PMID: 39641750
Purpose Of Review: Aspirin-exacerbated respiratory disease (AERD), a syndrome characterized clinically by asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions to aspirin and other cyclooxygenase-1 inhibitors, is an inflammatory...
5.
Mullur J, Maurer R, Ryan T, McGill A, Bensko J, Laidlaw T, et al.
Am J Rhinol Allergy
. 2024 Nov;
39(2):90-97.
PMID: 39574218
Background: Patients with aspirin-exacerbated respiratory disease (AERD) have difficult-to-treat asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and often require treatment with biologic therapy for asthma or CRSwNP. Healthcare utilization...
6.
Mullur J, Lundberg M, Maurer R, Laidlaw T, Buchheit K
Allergy Asthma Proc
. 2024 Nov;
45(6):421-425.
PMID: 39517071
Patients with aspirin-exacerbated respiratory disease (AERD) frequently experience symptoms consistent with eustachian tube dysfunction (ETD), which can substantially impair patient quality of life. We analyzed a cohort of 98 adult...
7.
Jacobs J, Han J, Lee J, Laidlaw T, Martin N, Caveney S, et al.
Adv Ther
. 2024 Nov;
42(1):510-522.
PMID: 39514041
Introduction: Tezepelumab blocks the activity of thymic stromal lymphopoietin, an epithelial cytokine implicated in the pathogenesis of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). In a previous analysis, tezepelumab...
8.
Minichetti D, Boyd A, Lemire E, Hacker J, Haber A, Roditi R, et al.
J Allergy Clin Immunol
. 2024 Sep;
155(1):120-134.
PMID: 39270802
Background: In 2% to 4% of patients, coronavirus disease 2019 (COVID-19) chemosensory dysfunction (CSD) persists beyond 6 months, accounting for up to 4 million people in the United States. The...
9.
Baloh C, Lim N, Huffaker M, Patel P, Tversky J, Du Toit G, et al.
World Allergy Organ J
. 2024 Sep;
17(8):100940.
PMID: 39247520
Antigen-specific IgG2 and IgG3 are rarely measured in food allergy clinical trials despite known function in preventing mast cell and basophil activation. Our objective was to determine whether measuring peanut-specific...
10.
Human nasal epithelial cells express IL-5Rα but not the co-receptor CSF2RB and do not signal to IL-5
Sohail A, Cho L, Hacker J, Bergmark R, Lee S, Maxfield A, et al.
Allergy
. 2024 Jul;
79(11):3146-3150.
PMID: 38972002
No abstract available.